TSS
REVB icon

Two Sigma Securities’s Revelation Biosciences REVB Stock Holding History

Two Sigma Securities’s Portfolio REVB Stock Details REVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-152
Closed -$13.4K – 2074
2024
Q4 		$13.4K Buy
+152
New +$20.3K ﹤0.01% 1389
2023
Q1 		– Hold
0
– -$7.49K – 3154
2022
Q4 		– Hold
0
– – – 2403
2022
Q3 		– Hold
0
– – – 2467

Other funds holding REVB

TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Two Sigma Securities's REVB Position: Q1 2025 in Review

Two Sigma Securities sold out of Revelation Biosciences (REVB) in Q1 2025, closing a stake of 152 shares — an estimated $13.4K sold.

Two Sigma Securities first reported a position in REVB in Q4 2024 and held it in 1 quarter. The position peaked at $13.4K in Q4 2024. 6 funds tracked by Wall St. Rank hold REVB as of Q1 2025.

  • Two Sigma Securities reported no remaining Revelation Biosciences position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Securities sold 152 Revelation Biosciences shares in Q1 2025, an estimated $13.4K.
  • Two Sigma Securities first reported a position in Revelation Biosciences in Q4 2024 and held it in 1 quarter.
  • Two Sigma Securities's Revelation Biosciences position peaked at $13.4K in Q4 2024.
  • 6 funds tracked by Wall St. Rank held Revelation Biosciences as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.